Gerhard is CEO and Co-Founder of Arkuda Therapeutics. Formerly he was CEO and president of Quartet Medicine. Prior to Quartet, he was Chief Scientific Officer and Senior Vice President of FORUM Pharmaceuticals where he developed a CNS-focused pipeline of small molecule therapeutics ranging from discovery-stage programs to phase 3 clinical programs. Prior to FORUM, Gerhard was Vice President, Scientific Programs and Evaluation for Fidelity Biosciences Group (now F’ Prime Capital). Before that, Gerhard was Director of the Dementia Research Department at Bayer. Gerhard has co-authored major scientific publications, patents, and reviews of new research findings in prestigious journals. He received his MS with honors and his PhD in Neurobiology, graduating summa cum laude from the University of Heidelberg, Germany.